Nav Bar

Wednesday, February 22, 2012

Feadships "Helix" Arrives in Asia

Feadship is taking a brand new Superyacht to Asia this spring. A dedicated tour by Helix 45m (147ft) will take in Hong Kong in March and the Hainan Rendezvous in early April before heading off to the Singapore boat show at the end of the month.

Feadship has an unrivalled pedigree in the Superyacht market and a history that goes back to 1849. Although the Dutch experts were building large yachts for Middle Eastern and European royalty in the 1930s, many maritime historians point to the 1951 New York Boat Show as the defining moment in the Feadship success story. This was the first time that Feadship had displayed its yachts to the American public, which expressed immediate admiration for the quality and craftsmanship. More than half of the 250 Feadships launched have been created for owners in the United States. Now with the arrival of Helix in China, Feadship is set to embark on a new phase in superyacht history.

Feadship director Dick van Lent, who will be among the senior Feadship managers accompanying Helix on this Asian tour comments;“Each Feadship is totally unique and each reflects our commitment to set new standards in terms of perfect craftsmanship and superior technology.”

Helix can accommodate 10 guests in 4 guest suites and a master suite which is forward on the main deck. All guests enjoy phenomenal views from their cabins which will be seen by invited guests and potential clients who will be given personal tours of the yacht. She will be on tour in Asia from 18th March through 29th April and will be staying at the Gold Coast Marina in Hong Kong from March 18 to 31. She will then head for the third Hainan Rendezvous, which is being held at the Visun Royal Yacht Club from April 5th to 8th. She will also attend the Singapore yacht show from April 27th to 29th.

For more information or to arrange a private viewing, or a meeting with the Feadship directors, please email Jan-Bart Verkuyl at jbverkuyl@lentyard.feadship.nl.

No comments:

Post a Comment